AAV Contract Development and Manufacturing Organizations Market Size, Share, Trends, Growth Outlook

AAV Contract Development and Manufacturing Organizations Market is estimated to increase at a growth rate of 18.8% CAGR over the forecast period from 2024 to 2030.

The AAV Contract Development and Manufacturing Organizations Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Workflow (Upstream Processing, Downstream Processing), By Type (Adherent Culture, Suspension Culture), By Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic & Research Institutes).

An Introduction to AAV Contract Development and Manufacturing Organizations Market in 2024

The AAV Contract Development and Manufacturing Organizations (CDMO) Market in 2024 are witnessing remarkable growth, driven by the expanding demand for adeno-associated virus (AAV) vectors in gene therapy and biopharmaceutical development. AAV vectors serve as versatile gene delivery vehicles, facilitating the transfer of therapeutic genes into target cells for the treatment of genetic disorders, neurodegenerative diseases, and cancer. Contract Development and Manufacturing Organizations play a pivotal role in providing end-to-end services, including process development, scale-up manufacturing, and quality control testing, to support the production of AAV-based therapeutics. With advancements in viral vector engineering, purification techniques, and regulatory compliance, the AAV CDMO market offers tailored solutions to biotechnology and pharmaceutical companies, enabling accelerated development timelines, scalability, and commercialization of gene therapy products.

AAV Contract Development and Manufacturing Organizations Market Trend: Increasing Demand for Viral Vector-Based Therapies

A prominent trend in the AAV Contract Development and Manufacturing Organizations (CDMOs) market is the growing demand for viral vector-based therapies. As gene therapy and gene editing technologies continue to advance, AAV (adeno-associated virus) vectors have emerged as a preferred delivery system for gene therapies due to their safety profile and efficacy. This trend drives the need for specialized CDMOs capable of providing comprehensive services for AAV-based therapeutics, including development, manufacturing, and analytical testing.

AAV Contract Development and Manufacturing Organizations Market Driver: Expanding Pipeline of Gene Therapy Products

The primary driver fueling the AAV CDMOs market is the expanding pipeline of gene therapy products in clinical development. With an increasing number of biopharmaceutical companies focusing on gene therapy as a treatment modality for various genetic and acquired diseases, there is a growing demand for outsourcing manufacturing and development activities to specialized CDMOs. This surge in demand is driven by the complexity of AAV-based therapies and the need for expertise in process development, scale-up, and manufacturing to meet regulatory requirements.

AAV Contract Development and Manufacturing Organizations Market Opportunity: Offering Integrated Solutions and Technology Platforms

An opportunity for AAV CDMOs lies in offering integrated solutions and technology platforms to streamline the development and manufacturing process for gene therapy products. By providing end-to-end services encompassing process development, manufacturing, analytics, and regulatory support, CDMOs can differentiate themselves in the market and become preferred partners for biopharmaceutical companies. Additionally, investing in innovative technologies and platforms for AAV production, purification, and characterization can further enhance efficiency and accelerate time to market for gene therapy products.

AAV Contract Development and Manufacturing Organizations Market Segmentation

By Workflow
Upstream Processing
-Vector Amplification & Expansion
-Vector Recovery & Harvesting
Downstream Processing
-Purification
-Fill Finish
By Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
By End-user
Pharmaceutical and Biopharmaceutical Companies
Academic & Research Institutes

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

AAV Contract Development and Manufacturing Organizations Market Companies

Thermo Fischer Scientific Inc
Creative Biogene
Catalent Inc
Charles River Laboratories International Inc
Danaher (Aldevron)
Forge Biologics
Genezen
ViroCell Biologics
Merck KGaA
VIRALGEN
Biovian Oy
Esco Lifesciences
GenScript ProBio
Porton Advanced Solution Ltd
Ask Bio
Showa Denko
Takara Bio Inc
ABL Manufacturing
Oxford Biomedica
Belief Biomed Inc
Beijing Anlong Biomedicine Co., Ltd
Forecyte Bio Limited
Gene Pharma Inc
Skyline Therapeutics
TFBS Bioscience Inc

 

 

Reasons to Buy the AAV Contract Development and Manufacturing Organizations Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the AAV Contract Development and Manufacturing Organizations Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the AAV Contract Development and Manufacturing Organizations Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 AAV Contract Development and Manufacturing Organizations Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global AAV Contract Development and Manufacturing Organizations Market Size Outlook, $ Million, 2021 to 2030
3.2 AAV Contract Development and Manufacturing Organizations Market Outlook by Type, $ Million, 2021 to 2030
3.3 AAV Contract Development and Manufacturing Organizations Market Outlook by Product, $ Million, 2021 to 2030
3.4 AAV Contract Development and Manufacturing Organizations Market Outlook by Application, $ Million, 2021 to 2030
3.5 AAV Contract Development and Manufacturing Organizations Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of AAV Contract Development and Manufacturing Organizations Market Industry
4.2 Key Market Trends in AAV Contract Development and Manufacturing Organizations Market Industry
4.3 Potential Opportunities in AAV Contract Development and Manufacturing Organizations Market Industry
4.4 Key Challenges in AAV Contract Development and Manufacturing Organizations Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global AAV Contract Development and Manufacturing Organizations Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global AAV Contract Development and Manufacturing Organizations Market Outlook By Segments
7.1 AAV Contract Development and Manufacturing Organizations Market Outlook by Segments
By Workflow
Upstream Processing
-Vector Amplification & Expansion
-Vector Recovery & Harvesting
Downstream Processing
-Purification
-Fill Finish
By Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
By End-user
Pharmaceutical and Biopharmaceutical Companies
Academic & Research Institutes


8 North America AAV Contract Development and Manufacturing Organizations Market Analysis And Outlook To 2030
8.1 Introduction to North America AAV Contract Development and Manufacturing Organizations Markets in 2024
8.2 North America AAV Contract Development and Manufacturing Organizations Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America AAV Contract Development and Manufacturing Organizations Market size Outlook by Segments, 2021-2030
By Workflow
Upstream Processing
-Vector Amplification & Expansion
-Vector Recovery & Harvesting
Downstream Processing
-Purification
-Fill Finish
By Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
By End-user
Pharmaceutical and Biopharmaceutical Companies
Academic & Research Institutes


9 Europe AAV Contract Development and Manufacturing Organizations Market Analysis And Outlook To 2030
9.1 Introduction to Europe AAV Contract Development and Manufacturing Organizations Markets in 2024
9.2 Europe AAV Contract Development and Manufacturing Organizations Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe AAV Contract Development and Manufacturing Organizations Market Size Outlook By Segments, 2021-2030
By Workflow
Upstream Processing
-Vector Amplification & Expansion
-Vector Recovery & Harvesting
Downstream Processing
-Purification
-Fill Finish
By Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
By End-user
Pharmaceutical and Biopharmaceutical Companies
Academic & Research Institutes


10 Asia Pacific AAV Contract Development and Manufacturing Organizations Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific AAV Contract Development and Manufacturing Organizations Markets in 2024
10.2 Asia Pacific AAV Contract Development and Manufacturing Organizations Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific AAV Contract Development and Manufacturing Organizations Market size Outlook by Segments, 2021-2030
By Workflow
Upstream Processing
-Vector Amplification & Expansion
-Vector Recovery & Harvesting
Downstream Processing
-Purification
-Fill Finish
By Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
By End-user
Pharmaceutical and Biopharmaceutical Companies
Academic & Research Institutes


11 South America AAV Contract Development and Manufacturing Organizations Market Analysis And Outlook To 2030
11.1 Introduction to South America AAV Contract Development and Manufacturing Organizations Markets in 2024
11.2 South America AAV Contract Development and Manufacturing Organizations Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America AAV Contract Development and Manufacturing Organizations Market size Outlook by Segments, 2021-2030
By Workflow
Upstream Processing
-Vector Amplification & Expansion
-Vector Recovery & Harvesting
Downstream Processing
-Purification
-Fill Finish
By Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
By End-user
Pharmaceutical and Biopharmaceutical Companies
Academic & Research Institutes


12 Middle East And Africa AAV Contract Development and Manufacturing Organizations Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa AAV Contract Development and Manufacturing Organizations Markets in 2024
12.2 Middle East and Africa AAV Contract Development and Manufacturing Organizations Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa AAV Contract Development and Manufacturing Organizations Market size Outlook by Segments, 2021-2030
By Workflow
Upstream Processing
-Vector Amplification & Expansion
-Vector Recovery & Harvesting
Downstream Processing
-Purification
-Fill Finish
By Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
By End-user
Pharmaceutical and Biopharmaceutical Companies
Academic & Research Institutes


13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Thermo Fischer Scientific Inc
Creative Biogene
Catalent Inc
Charles River Laboratories International Inc
Danaher (Aldevron)
Forge Biologics
Genezen
ViroCell Biologics
Merck KGaA
VIRALGEN
Biovian Oy
Esco Lifesciences
GenScript ProBio
Porton Advanced Solution Ltd
Ask Bio
Showa Denko
Takara Bio Inc
ABL Manufacturing
Oxford Biomedica
Belief Biomed Inc
Beijing Anlong Biomedicine Co., Ltd
Forecyte Bio Limited
Gene Pharma Inc
Skyline Therapeutics
TFBS Bioscience Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Workflow
Upstream Processing
-Vector Amplification & Expansion
-Vector Recovery & Harvesting
Downstream Processing
-Purification
-Fill Finish
By Type
Adherent Culture
Suspension Culture
By Application
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
By End-user
Pharmaceutical and Biopharmaceutical Companies
Academic & Research Institutes